Emerson acquires life sciences software firm Fluxa

Emerson has acquired Fluxa, a life sciences software company whose PKM software accelerates drug development and manufacturing; Fluxa will be integrated with Emerson's DeltaV control system. The deal was reported on October 5, 2022.

“Emerson has acquired Fluxa, a leader in the life sciences industry that uses software and modern technology architectures to accelerate the speed to market for new therapies, drugs and vaccines.”valvemagazine.com

• 1 source
• valvemagazine.comIndustry Capsules - Valve MagazineOct 5, 2022

Summarized from public sources; check the original articles before acting on it.